TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15409 · Jan 12

#javascript#agentic_ai#agentic_engineering#agentic_framework#agentic_rag#agentic_workflow#ai_assistant#ai_tools#anthropic_claude#autonomous_agents#claude_code#codex#huggingface#jules#mcp_server#model_context_protocol#multi_agent#multi_agent_systems#npx#swarm#swarm_intelligence Claude-Flow v2.7 is an enterprise AI platform with hive-mind swarms, 25 natural language skills, 100+ tools, and AgentDB integration for 96x-164x faster semantic search and 4-32x less memory use. Install via `npx claude-flow@alpha init` after Claude Code, then use commands like `swarm "build API"` for quick tasks or hive-mind for projects. It boosts your coding speed with 84.8% problem-solving rate, automation, GitHub tools, and persistent memory—saving you hours on complex development. https://github.com/ruvnet/claude-flow

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment